The goal of my research program at the Sloan Kettering Institute over the past three decades plus has been the understanding of the natural history of genomic instability in cancer cells and its implication to clinical behavior of tumors on the one hand, and to normal cellular developmental pathways on the other. Over this time period, the tools to identify, measure, and analyze the mechanisms of genomic instability have evolved remarkably.
Raju Chaganti, PhD
Emeritus
Professor
Research Focus
Geneticist Raju Chaganti studies genomic instability in cancer cells and its implications for clinical behavior of tumors and normal cellular developmental pathways.Education
PhD, Harvard University- Office Phone: 212-639-8121
- Lab Phone: 212-639-8281/8282
- Lab Fax: 212-717-3541
Lab Members
Nirmala Jagadish
Research Scholar
Ritu Kushwaha
Research Scholar
Miguel Lopez-Lago
Research Associate
Rahuldev Malage
Research Fellow
Geetu Mendiratta
Research Fellow
Rekha Soni
Research Assistant
Publications
- Chaganti, R.S.K., and Nanjangud, G. Cytogenetics of lymphoma. In: Non-Hodgkin’s lymphomas (Mauch, P.M., Armitage, J.O., Coiffier, B., and Dalla-Favera, R., Harris, N.L., eds.) Lippincott, Williams & Wilkins, Baltimore, pp809-824, 2003.
- Pasqualucci, L., Migliazza, A., Chaganti, R.S.K., Ye, H. B., and Dalla-Favera, R. Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma. Blood 101: 2914-2923, 2003.
